SM
MDCO

Sabby Management’s Medicines Co MDCO Stock Holding History

Sabby Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-127
Closed -$483K – 235
2017
Q2 		$483K Buy
+127
New +$5.66K 0.03% 140
2017
Q1 		– Sell
-1,172
Closed -$3.98M – 351
2016
Q4 		$3.98M Buy
1,172
+1,072
+1,072% +$38K 0.23% 63
2016
Q3 		$377K Hold
100
– – 0.01% 242
2016
Q2 		$336K Buy
+100
New +$3.53K 0.02% 226
2015
Q3 		– Sell
-803
Closed -$2.3M – 422
2015
Q2 		$2.3M Buy
803
+65
+9% +$1.81K 0.08% 154
2015
Q1 		$2.07M Buy
738
+576
+356% +$16.2K 0.09% 143
2014
Q4 		$448 Buy
162
+21
+15% +$520 0.01% 191
2014
Q3 		$315 Sell
141
-43
-23% -$1.09K 0.01% 207
2014
Q2 		$535K Hold
184
– – 0.02% 187
2014
Q1 		$523K Buy
+184
New +$6.09K 0.03% 176

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management's MDCO Position: Q3 2017 in Review

Sabby Management sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 11,764 shares — an estimated $434K sold.

Sabby Management first reported a position in MDCO in Q2 2014 and held it in 5 quarters. The position peaked at $3.81M in Q4 2016. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Sabby Management reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 11,764 Medicines Co shares in Q3 2017, an estimated $434K.
  • Sabby Management first reported a position in Medicines Co in Q2 2014 and held it in 5 quarters.
  • Sabby Management's Medicines Co position peaked at $3.81M in Q4 2016.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.